NeuroBo Pharmaceuticals, Inc. Made Big Gain

NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ) rocketted at $29.9, a gain of 79.3%. On Tue, Sep 13, 2022, NRBO:NASDAQ touched a New 2-Week High of $29.9. The stock appeared on our News Catalysts scanner on Mon, Sep 12, 2022 at 10:13 AM in the 'SPLIT' category. From Tue, Aug 30, 2022, the stock recorded 33.33% Up Days and 60.00% Green Days

The stock spiked on Tue, Sep 13, 2022 at $63.85 with a volume of 9M+.

About NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ)

NeuroBo Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing therapies for patients with diabetic neuropathy and Alzheimer's disease. Its product candidate comprises NB-01, which is primarily focused on the development of a treatment for painful diabetic neuropathy; NB-02, which treat the symptoms of neurodegenerative diseases associated with the malfunction of a protein called tau, and with amyloid-beta plaque deposition; Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia.